(firstQuint)DCE-MRI Using Dotarem in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC.

 Secondary objectives : 1.

 To evaluate the value of percent change of DCE-MRI/AFP/DWI from baseline to follow up at 1 or 2 weeks in prediction of overall survival, progression-free survival, and time to progression 2.

 To evaluate the value of baseline DCE-MRI/AFP/DWI in prediction of overall survival, progression-free survival, and time to progression.

.

 DCE-MRI Using Dotarem in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC@highlight

Primary objective : The main objective is to evaluate the value of DCE-MRI in prediction of response of patients with HCC to treatment with Sorafenib assessed by mRECIST.

